RT @ANZMTG: The ANZMTG 01.15 CHARLI trial is investigating the efficacy and safety of combining denosumab with immunotherapies; either with…
RT @DrCraigGedye: Thanks to coauthors of our review on #RANKL #drugrepurposing which we hope will improve #cancer treatments like #immunoth…
RT @ANZMTG: The ANZMTG 01.15 CHARLI trial is investigating the efficacy and safety of combining denosumab with immunotherapies; either with…
RT @ANZMTG: The ANZMTG 01.15 CHARLI trial is investigating the efficacy and safety of combining denosumab with immunotherapies; either with…
RT @ANZMTG: The ANZMTG 01.15 CHARLI trial is investigating the efficacy and safety of combining denosumab with immunotherapies; either with…
The ANZMTG 01.15 CHARLI trial is investigating the efficacy and safety of combining denosumab with immunotherapies; either with nivolumab OR ipilimumab + nivolumab #melanoma #clinicalresearch
Thanks to coauthors of our review on #RANKL #drugrepurposing which we hope will improve #cancer treatments like #immunotherapy. @ANZUPtrials #KeyPAD trial, @Shahneen3 @ANZMTG #CHARLI trial and @QIMRBerghofer basic research will give us more answers https:/